MedPath

Diagnostic value of three-dimensional ultrasound in breast cancer screening participants referred with a BI-RADS 0 test result: a comparison of imaging strategies

Completed
Conditions
breast cancer
breast neoplasm
10006291
Registration Number
NL-OMON47752
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
600
Inclusion Criteria

Participants of Dutch breast cancer screening with a BI-RADS 0 mammography result, who are referred to one of the participating hospitals for further diagnostic work-up.

Exclusion Criteria

Inability to understand study information

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is the accuracy of different imaging strategies in<br /><br>diagnosing breast cancer, expressed as the area under the receiver operating<br /><br>characteristic (ROC) curve. Pathology or the results of all imaging modalities<br /><br>are used as the reference standard. All study participants will be followed up<br /><br>to the next scheduled screening round approximately 2 years later to determine<br /><br>if any breast cancer was missed. The imaging modalities under study,<br /><br>supplemental to the full-field digital screening mammography, are 3DUS, digital<br /><br>breast tomosynthesis (DBT) and handheld ultrasound (HHUS).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The diagnostic accuracy of the different imaging strategies among subgroups of<br /><br>patients based on mammographic density and age.<br /><br>The biopsy referral rate for the different imaging strategies under study.<br /><br>The interobserver reliability for 3DUS.</p><br>
© Copyright 2025. All Rights Reserved by MedPath